Aevi Genomic Medicine (Aevi Genomic Medicine) Pre-Tax Income : $-19.15 Mil (TTM As of Sep. 2019)

Aevi Genomic Medicine Pre-Tax Income Chart

Aevi Genomic Medicine Annual Data
	Trend	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18
Pre-Tax Income		Get a 7-Day Free Trial					-18.42	-37.98	-41.89	-34.71	-30.78

Aevi Genomic Medicine Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Pre-Tax Income	Get a 7-Day Free Trial															-7.25	-6.63	-4.84	-3.65	-4.04

Competitive Comparison of Aevi Genomic Medicine's Pre-Tax Income

For the Biotechnology subindustry, Aevi Genomic Medicine's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aevi Genomic Medicine's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aevi Genomic Medicine's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Aevi Genomic Medicine's Pre-Tax Income falls into.

Aevi Genomic Medicine Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Aevi Genomic Medicine's Pretax Income for the fiscal year that ended in Dec. 2018 is calculated as

Aevi Genomic Medicine's Pretax Income for the quarter that ended in Sep. 2019 is calculated as

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $-19.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aevi Genomic Medicine  (NAS:GNMX) Pre-Tax Income Explanation

Aevi Genomic Medicine's Pretax Margin for the quarter that ended in Sep. 2019 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aevi Genomic Medicine Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Aevi Genomic Medicine's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Aevi Genomic Medicine (Aevi Genomic Medicine) Business Description